Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Revenue

Frontier Biotechnologies had revenue of 28.33M CNY in the quarter ending March 31, 2025, with 14.93% growth. This brings the company's revenue in the last twelve months to 133.15M, up 4.86% year-over-year. In the year 2024, Frontier Biotechnologies had annual revenue of 129.47M with 13.32% growth.

• Revenue (ttm): 133.15M
• Revenue Growth: +4.86%
• P/S Ratio: 60.57
• Revenue / Employee: 440.90K
• Employees: 302
• Market Cap: 8.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	129.47M	15.22M	13.32%
Dec 31, 2023	114.25M	29.51M	34.82%
Dec 31, 2022	84.74M	44.24M	109.22%
Dec 31, 2021	40.50M	-6.12M	-13.13%
Dec 31, 2020	46.62M	25.76M	123.50%